3,4-Dihydro-2H-1,5-benzodioxepine,
7216-18-4,
3,4-Dihydro-2H-benzo[b][1,4]dioxepine,
2H-1,5-Benzodioxepin, 3,4-dihydro-,
1,2-TRIMETHYLENEDIOXYBENZENE,
Pyrocatechol trimethylene ether,
BRN 0128377,
3,4-dihydro-2h-1,5-benzodioxepin,
3,4-Dihydro-2H-1,4-benzodioxepin,
CBXMULHQEVXJDI-UHFFFAOYSA-N,
MFCD01333457,
2H,3H,4H-benzo[b]1,4-dioxepin,
AC1Q1HME,
AC1Q1IBG,
1,5-BENZODIOXEPANE,
SCHEMBL9351,
5-19-01-00450 (Beilstein Handbook Reference),
AC1L31R4,
SCHEMBL4506587,
DTXSID20222500,
HMS1718J12,
ZINC5175379,
1200AC,
ANW-54528,
SBB016570,
AKOS000121570,
ACN-054413,
MCULE-2178861428,
NE11848,
TRA0100659,
3,4-Dihydro-2H-1,5-benzodioxepine #,
AJ-53464,
AN-13336,
AS-31223,
CJ-12493,
EN001323,
LS-34515,
SC-26913,
SY003809,
AB0052632,
TC-069542,
FT-0083254,
FT-0651337,
ST50329624,
EN300-17581,
MFCD01333457 (97+%),
I14-12997,
F3284-8044,
C9H10O2,
CID81635,
AR-1E9161,
C9-H10-O2,
7494-27-1,